AL
TVTX icon

AJO LP’s Travere Therapeutics TVTX Stock Holding History

AJO LP’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,664
Closed -$159K – 630
2020
Q3 		$159K Sell
8,664
-6,183
-42% -$120K ﹤0.01% 614
2020
Q2 		$303K Buy
14,847
+7,343
+98% +$117K ﹤0.01% 565
2020
Q1 		$109K Sell
7,504
-7,158
-49% -$108K ﹤0.01% 593
2019
Q4 		$208K Buy
+14,662
New +$187K ﹤0.01% 507
2018
Q1 		– Sell
-28,395
Closed -$598K – 679
2017
Q4 		$598K Buy
+28,395
New +$649K ﹤0.01% 531
2017
Q3 		– Sell
-59,681
Closed -$1.16M – 616
2017
Q2 		$1.16M Buy
59,681
+1,094
+2% +$19.8K ﹤0.01% 483
2017
Q1 		$1.08M Sell
58,587
-1,047
-2% -$20.5K ﹤0.01% 420
2016
Q4 		$1.13M Sell
59,634
-107,890
-64% -$2.21M ﹤0.01% 408
2016
Q3 		$3.75M Buy
+167,524
New +$3.19M 0.02% 301

Other funds holding TVTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AJO LP's TVTX Position: Q4 2020 in Review

AJO LP sold out of Travere Therapeutics (TVTX) in Q4 2020, closing a stake of 8,664 shares — an estimated $159K sold.

AJO LP first reported a position in TVTX in Q3 2016 and held it in 9 quarters. The position peaked at $3.75M in Q3 2016. 138 funds tracked by Wall St. Rank hold TVTX as of Q4 2020.

  • AJO LP reported no remaining Travere Therapeutics position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 8,664 Travere Therapeutics shares in Q4 2020, an estimated $159K.
  • AJO LP first reported a position in Travere Therapeutics in Q3 2016 and held it in 9 quarters.
  • AJO LP's Travere Therapeutics position peaked at $3.75M in Q3 2016.
  • 138 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.